Since both patients did not exhibit symptoms of pneumonia at the time of surgery, these 35 changes likely represent an early phase of the lung pathology of COVID-19 pneumonia. 36 37
Abstract 26 There is currently a lack of pathologic data on the novel coronavirus (SARS-CoV-2) 27 pneumonia, or COVID-19, from autopsy or biopsy. Two patients who recently 28 underwent lung lobectomies for adenocarcinoma were retrospectively found to have had 29 COVID-19 at the time of surgery. These two cases thus provide important first 30 opportunities to study the pathology of COVID-19. Pathologic examinations revealed 31 that, apart from the tumors, the lungs of both patients exhibited edema, proteinaceous 32 exudate, focal reactive hyperplasia of pneumocytes with patchy inflammatory cellular 33 infiltration, and multinucleated giant cells. Hyaline membranes were not prominent. various degrees of pulmonary abnormalities on chest CT imaging [1, 3] . Although the vast 48 majority of patients only have a common, mild form of illness, about 15-20% of the 49 patients fall into the severe group, meaning they require assisted oxygenation as part of 50 treatment [3] . The severe group has a high mortality rate and is associated with older age, 51 underlying diseases such as diabetes, and medical procedures (such as patients who were 52 infected in a hospital setting while receiving surgery for other indications).
53
Although there have been several studies describing clinical features and 54 characteristic radiographic findings (mainly chest CT scans) [1, 3] , no pathologic studies 55 have been conducted based on autopsies or biopsies. Some of the reasons for the lack of 56 autopsies and biopsies include the suddenness of the outbreak, the vast patient volume in 57 hospitals, shortage of healthcare personnel, and the high rate of transmission, which 58 makes invasive diagnostic procedures less of a clinical priority.
59
Fortunately and unfortunately, we encountered two patients who underwent 60 surgery for malignancy and were later found to have been infected with SARS-CoV-2.
61
The surgical specimens overlapped in time with the infection, which offered us the 62 4 necessary specimens to examine the histopathology of COVID-19 pneumonia. . White blood cell count was 12.49×10 12 /L, while lymphocyte count was lowered to 77 0.4×10 9 /L and the differential to 5%. There was a slight wheezing sound to auscultation 78 on the right side. On Day 16, the patient developed some difficulty in breathing, chest 79 tightness, wheezing, and dry cough. She was diagnosed as "suspicious for viral 80 pneumonia," with intermittent SpO2 between 72% and 88%. On Day 24, she was 81 transferred to the special isolation ward due to a pharyngeal swab test positive for the 82 2019-nCoV. The labs drawn from the day before (Day 23) showed white blood cell 33.52 83 ×10^9/L ; neutrophils 89.80% ; lymphocytes 1.90% ; eosinophils 0% ; neutrophil Subsequent clinical information confirmed that she was exposed to another 91 patient in the same room who was subsequently found to be infected with the 92 2019-nCoV.
93
The right middle lobe resection specimen was delivered to the surgical pathology Compared with pathological findings in a cohort of autopsy cases of SARS, the two cases 170 presented here also exhibited exudative and proliferative phase acute lung injury such as 171 edema, inflammatory infiltrate, type II pneumocyte hyperplasia, and organization, but 172 9 without obvious hyaline membrane formation and other chronic process such as 173 squamous metaplasia [5] [6] [7] . Of note, pathologic changes seen in our two cases proceeded 174 the development of clinical symptoms, and likely represent an earlier phase of the disease.
175
Future studies in autopsies may add to the current findings.
176
Although patient #1 was never febrile, her CBC profile, especially from post-op 177 Day 1, showed high WBC counts and lymphocytopenia, which is consistent with 178 COVID-19. This may be a good clue for early diagnosis in the future. CASE 2 developed 179 a fever a few days after the CT findings, suggesting a delay in symptom development in 180 these patients. During the earlier days of the outbreak, there had been limitations in both 181 capacity and turnaround time for the nucleic acid test, which had further caused delay in 182 confirming the diagnosis of COVID-19 [4] in many patients. It seems that the time for the 183 early lung lesions or COVID-19 to become severe enough to cause clinical symptoms is 184 rather long. Even among patients with fevers, the commonly used pharyngeal swab PCR 185 test may be negative, due to the lack of viruses in the upper respiratory tract despite the 186 presence of pneumonia. However, radiographic changes can occur early (chest CT scan is 187 mostly employed in China during the current outbreak). Therefore, during an epidemic 188 season, it is prudent to carefully evaluate any lung infiltration for the ground glass opacity, 189 and an appropriate serology test be used to rule out potential infection 4 .
190
These two incidences also typify a common scenario during the earlier phase of 191 the SARS-CoV-2 outbreak, during which a significant number of healthcare providers 192 became infected in hospitals in Wuhan, and patients in the same room were cross-infected, 193 as they were exposed to unknown transmission sources. Because of this, it is important 
